RPAM
DNLI icon

Rhenman & Partners Asset Management’s Denali Therapeutics DNLI Stock Holding History

Rhenman & Partners Asset Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Quarter Market Value Status Shares Shares
Change % 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		$1.4M Hold
100,000
– – 0.18% 80
2025
Q1 		$1.36M Buy
+100,000
New +$1.36M 0.16% 75